Wellington Management Group’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-216,286
Closed -$1.12M 1976
2025
Q4
$1.12M Sell
216,286
-12,855
-6% -$62.3K ﹤0.01% 1701
2025
Q3
$967K Sell
229,141
-190,290
-45% -$885K ﹤0.01% 1786
2025
Q2
$1.54M Buy
419,431
+173,883
+71% +$648K ﹤0.01% 1636
2025
Q1
$1.06M Sell
245,548
-8,734
-3% -$35.3K ﹤0.01% 1693
2024
Q4
$814K Buy
254,282
+12,634
+5% +$42.4K ﹤0.01% 1755
2024
Q3
$691K Buy
241,648
+17,842
+8% +$50K ﹤0.01% 1772
2024
Q2
$627K Buy
223,806
+17,960
+9% +$48.2K ﹤0.01% 1754
2024
Q1
$585K Buy
+205,846
New +$700K ﹤0.01% 1791

Other funds holding ORGO

Wellington Management Group's ORGO Position: Q1 2026 in Review

Wellington Management Group sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 216,286 shares — an estimated $1.12M sold.

Wellington Management Group first reported a position in ORGO in Q1 2024 and held it in 8 quarters. The position peaked at $1.54M in Q2 2025. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • Wellington Management Group reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
  • Wellington Management Group sold 216,286 Organogenesis Holdings shares in Q1 2026, an estimated $1.12M.
  • Wellington Management Group first reported a position in Organogenesis Holdings in Q1 2024 and held it in 8 quarters.
  • Wellington Management Group's Organogenesis Holdings position peaked at $1.54M in Q2 2025.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.